Infections in lung transplantation: New insights

Current Opinion in Organ Transplantation

Volumn 14, Issue 5, 2009, Pages 483-487

  Hafkin, Jeffrey ^a   Blumberg, Emily ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bronchiolitis obliterans; Burkholderia cepacia; Cytomegalovirus; Infection; Lung transplantation

Indexed keywords

BACTERIAL COLONIZATION; BRONCHIOLITIS OBLITERANS; BURKHOLDERIA INFECTION; CYSTIC FIBROSIS; GRAM NEGATIVE INFECTION; HUMAN; LUNG INFECTION; LUNG TRANSPLANTATION; MORTALITY; PATHOGENESIS; POSTOPERATIVE INFECTION; PSEUDOMONAS INFECTION; REVIEW;

BACTERIAL INFECTIONS; HUMANS; INCIDENCE; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS;

EID: 73349098377     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32833062f6     Document Type: Review

References (17)

1. Remund K, Best M, Egan J. Infections relevant to lung transplantation. Proc Am Thorac Soc 2009; 6:94-100. Up-to-date and concise review of the major infections complicating lung transplantation.
2. Mahenthiralingam E, Baldwin A, Dowson C. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 2008; 104:1539-1551.
3. Boussaud V, Guillerrmain R, Grenet D, et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonized with Burkholderia cepacia complex: results fromtwo French centres. Thorax 2008; 63:732-737.
4. Alexander B, Petzold E, Reller L, et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008; 8:1025-1030.
5. Murray S, Charbeneau J, Marshall B, et al. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008; 178:363-371. Represents the largest cohort study of the effect of Burkholderia species in CF lung transplant recipients.
6. Taylor D, Edwards L, Mohacsi P, et al. The Registry of the International Society for Heart and Lung Transplantation: Twentieth Official Adult Heart Transplant Report: 2003. J Heart Lung Transplant 2003; 22:616-624. (Pubitemid 36773674)
7. Estenne M, Hertz M. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002; 166:440-444.
8. Gottlieb J, Mattner F, Weissbrodt H, et al. Impact of graft colonization with Gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis. Respir Med 2009; 103:743-749.
9. Botha P, Archer L, Anderson R, et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008; 85:771-774.
10. Vos R, Vanaudenaerde B, Geudens N, et al. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Eur Respir J 2008; 31:1037-1045.
11. Hodson E, Craig J, Strippoli G, et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Review). Cochrane Database of Systemic Reviews 2009; 2:1-246.
12. Puius Y, Snydman D. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges. Curr Opin Infect Dis 2007; 20:419-424.
13. Chmiel C, Speich R, Hofer M, et al. Ganciclovir/V-alganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis 2008; 46:831-839.
14. Valentine V, Weill D, Gupta M, et al. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation. J Heart Lung Transplant 2008; 27:875-881.
15. Manuel O, Kumar D, Moussa G, et al. Lack of association between b-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis. Transplantation 2009; 87:719-725. Prospective study of BAL recovery of beta herpesviruses, evaluating the impact of viral isolation on BOS.
16. Reddy, A, Zaas A, Hanson K, et al. A Single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome 2007, 26:1286-1292.
17. Avery R. Update in management of ganciclovir-resistant cytomegalovirus infection. Curr Opin Infect Dis 2008; 21:433-437.